Checkpoint Capital »

Allakos shares owned by Checkpoint Capital

Quarter-by-quarter ownership of Allakos (ALLK) shares owned by Checkpoint Capital from 13F filings

Historical chart of Checkpoint Capital investment in Allakos

Tip: Access up to 7 years of quarterly data

All positions including Allakos held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allakos by Checkpoint Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 445k 2.73

More positions owned by Checkpoint Capital

Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Spdr Biotech Etf Tr Unit Put Option (XBI)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Springworks Therapeutics (SWTX)
Axsome Therapeutics (AXSM)
Mirum Pharmaceuticals (MIRM)
Protagonist Therapeutics (PTGX)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Phathom Pharmaceuticals (PHAT)
Atyr Pharma Com New (LIFE)
Trevi Therapeutics (TRVI)
Gh Research Ordinary Shares (GHRS)
Allakos (ALLK)

View all positions for Checkpoint Capital

Top funds holding Allakos

BVF
T. Rowe Price Associates
NEA Management Company
RiverVest Venture Management
Blackstone Group
Redmile Group
Citadel Advisors
Vanguard Group
Vivo Capital
Logos Global Management
Millennium Management
Vontobel Holding
EcoR1 Capital
Checkpoint Capital
Clearline Capital

View all funds holding Allakos